XML 99 R43.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Segment Reporting and Foreign Operations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Segment Reporting [Abstract] |
Schedule of Long-lived Assets by Geographic Area | Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2024, 2023 and 2022, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2024 |  | 2023 |  | 2022
United States | ​ | $ | 271,734 | ​ | $ | 273,105 | ​ | $ | 281,290
Ireland | ​ |  | 45,325 | ​ |  | 42,333 | ​ |  | 40,749
Other foreign countries | ​ |  | 69,106 | ​ |  | 68,085 | ​ |  | 60,937
Total | ​ | $ | 386,165 | ​ | $ | 383,523 | ​ | $ | 382,976
Schedule of Segment Reporting Information, by Segment | Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2024, 2023 and 2022, are as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended | ​ | Year Ended | ​ | Year Ended
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | December 31, 2022
​ |  | Cardiovascular |  | Endoscopy |  | Consolidated |  | Cardiovascular |  | Endoscopy |  | Consolidated |  | Cardiovascular |  | Endoscopy |  | Consolidated
Net sales |  | $ | 1,301,744 |  | $ | 54,770 |  | $ | 1,356,514 |  | $ | 1,220,560 | ​ | $ | 36,806 |  | $ | 1,257,366 |  | $ | 1,118,224 |  | $ | 32,757 |  | $ | 1,150,981
Cost of sales standard(1) | ​ | ​ | 549,657 | ​ | ​ | 15,746 | ​ | ​ | ​ | ​ | ​ | 534,826 | ​ | ​ | 12,987 | ​ | ​ | ​ | ​ | ​ | 496,678 | ​ | ​ | 12,739 | ​ | ​ | ​
Cost of sales other(2) | ​ |  | 140,948 | ​ |  | 6,830 | ​ |  | ​ | ​ |  | 125,388 | ​ |  | 293 | ​ |  | ​ | ​ |  | 121,045 | ​ |  | 1,420 | ​ |  | ​
Selling, general and administrative expenses | ​ |  | 376,734 | ​ |  | 22,997 | ​ |  | ​ | ​ |  | 362,082 | ​ |  | 11,594 | ​ |  | ​ | ​ |  | 332,012 | ​ |  | 10,513 | ​ |  | ​
Research and development expenses | ​ | ​ | 83,812 | ​ | ​ | 3,654 | ​ | ​ | ​ | ​ | ​ | 80,300 | ​ | ​ | 2,428 | ​ | ​ | ​ | ​ | ​ | 74,042 | ​ | ​ | 1,468 | ​ | ​ | ​
Other operating expenses(3) | ​ | ​ | 443 | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 3,524 | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 13,501 | ​ | ​ | — | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income from operations | ​ | $ | 150,150 | ​ | $ | 5,543 | ​ | $ | 155,693 | ​ | $ | 114,440 | ​ | $ | 9,504 | ​ | $ | 123,944 | ​ | $ | 80,946 | ​ | $ | 6,617 | ​ | $ | 87,563
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (5,700) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (11,855) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (4,934)
​ | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Income before income taxes | ​ |  | ​ | ​ | ​ | ​ | ​ | $ | 149,993 | ​ |  | ​ | ​ | ​ | ​ | ​ | $ | 112,089 | ​ |  | ​ | ​ | ​ | ​ | ​ | $ | 82,629
​
(1) | Cost of sales standard represents costs of goods sold measured at the internal standard cost for production of inventory. Inventory standard costs include material, labor and manufacturing overhead.
(2) | Cost of sales other for all segments include amortization expense associated with our developed technology and license agreement intangible assets, freight and handling associated with shipments to customers, provisions based on estimated excess, slow moving and obsolete inventories, manufacturing and price variances, and royalties.
(3) | Other operating expenses include impairment charges, contingent consideration (benefit expense) related to the changes in fair value of contingent payments associated with acquisitions, acquired in-process research and development expense, and certain legal settlements.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2024 |  | 2023 |  | 2022
Cardiovascular | ​ | $ | 97,749 | ​ | $ | 88,960 | ​ | $ | 80,777
Endoscopy | ​ |  | 4,960 | ​ |  | 1,025 | ​ |  | 1,027
Total | ​ | $ | 102,709 | ​ | $ | 89,985 | ​ | $ | 81,804
Total depreciation and amortization by operating segment for the years ended December 31, 2024, 2023 and 2022, consisted of the following (in thousands):

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration